Endoscopic retrograde cholangiopancreatography guided interventions in the management of pancreatic cancer

World J Gastrointest Endosc. 2020 Oct 16;12(10):323-340. doi: 10.4253/wjge.v12.i10.323.

Abstract

Pancreatic cancer is the leading cause of cancer-related morbidity and mortality with an overall five-year survival of less than 9% in the United States. At presentation, the majority of patients have painless jaundice, pruritis, and malaise, a triad that develops secondary to obstruction, which often occurs late in the course of the disease process. The technical advancements in radiological imaging and endoscopic interventions have played a crucial role in the diagnosis, staging, and management of patients with pancreatic cancer. Endoscopic retrograde cholangiopancreatography (ERCP)-guided diagnosis (with brush cytology, serial pancreatic juice aspiration cytologic examination technique, or biliary biopsy) and therapeutic interventions such as pancreatobiliary decompression, intraductal and relief of gastric outlet obstruction play a pivotal role in the management of advanced pancreatic cancer and are increasingly used due to improved morbidity and complication rates compared to surgical management. In this review, we highlight various ERCP-guided diagnostic and therapeutic interventions for the management of pancreatic cancer.

Keywords: Biliary drainage; Biliary stent; Endoscopic retrograde cholangiopancreatography; Gastric outlet obstruction; Malignant stricture; Pancreatic cancer.

Publication types

  • Review